Cardioangiologisches Centrum Bethanien

REal-world Valued Outcomes of a noveL Balloon-in-basket pUlsed Field ablaTION Catheter for Atrial Fibrillation RegistrY

Role: lead

Ultrasound Guyded Venous Puncture for Safe AF Ablation Procedures

Role: lead

REFOCUS-AF - "RepEat Ablation With AFFERA vs. COntact Force-Guided RF Catheters for Optimal OUtcomes in Symptomatic AF".

Role: lead

Electroporation Treatment for Early AF Management in Heart Failure With Preserved Ejection Fraction (HFpEF) Pilot Study

Role: lead

Study Regarding the Incidence of Anti-platelet Factor 4-antibodies in Patients Aged 18 to 60 Years With Spontaneous or Infection- or Vaccine-associated or Recurrent Venous and/or Arterial Thrombosis

Role: lead

Prospective Comparison of Incidence of Heavy Menstrual Bleeding in Women Treated With Direct Oral Anticoagulants

Role: lead

Ex-vivo Effect of New Oral Anticoagulants on Point-of-care Devices

Role: lead

Ablation STrategies for Repeat PrOcedures in Patients With Atrial Fibrillation Recurrences

Role: lead

EUropean Real World Outcomes With Pulsed Field AblatiOn

Role: lead

Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome

Role: lead

Prospective Observational Study to Evaluate a Possible Change in APS Antibody Profiles After COVID-19 Infection or Vaccination

Role: lead

Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists (RADOA). Focus on New Antidots

Role: lead

Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists

Role: lead

Substudy - Evaluation of Patients With Iliac Vein Thrombosis

Role: lead

HeartLight Guided - Pure Pulmonary Vein Isolation Regardless of Concomitant Atrial Substrate

Role: lead

Frankfurt Thrombophilia Registry

Role: lead